Karla Reyna Navarro Fuentes

Karla Reyna Navarro Fuentes

Auto-generated profile, based on publicly available information

Karla Reyna Navarro Fuentes

Mexican Social Security Institute

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in American Journal of Infection Control
Verified
Journal Article
Closed access
VRVíctor Daniel Rosenthal
Víctor Daniel Rosenthal
DMDennis George Maki
Dennis George Maki
YMYatin Mehta
Yatin Mehta
HLHakan Leblebicioglu
Hakan Leblebicioglu
ZMZiad Ahmed Memish
Ziad Ahmed Memish
DADinh Pham Phuong Anh
Dinh Pham Phuong Anh

26 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
SRSupriya Ravichandran
Supriya Ravichandran
MHMegan Hahn
Megan Hahn
PBPablo F. Belaunzarán-Zamudio
Pablo F. Belaunzarán-Zamudio
JRJosé Ramos-Castañeda
José Ramos-Castañeda
GNGabriel Nájera-Cancino
Gabriel Nájera-Cancino
SKSurender Khurana
Surender Khurana
Zika virus (ZIKV) outbreak in Americas led to extensive efforts to develop vaccines and ZIKV-specific diagnostics. In the current study, we use whole genome phage display library spanning the entire ZIKV genome (ZIKV-GFPDL) for in-depth immune profiling of IgG and IgM antibody repertoires in serum and urine longitudinal samples from individuals acutely infected with ZIKV. We observe a very diverse IgM immune repertoire encompassing the entire ZIKV polyprotein on day 0 in both serum and urine. ZIKV-specific IgG antibodies increase 10-fold between day 0 and day 7 in serum, but not in urine; these are highly focused on prM/E, NS1 and NS2B. Differential antibody affinity maturation is observed against ZIKV structural E protein compared with nonstructural protein NS1. Serum antibody affinity to ZIKV-E protein inversely correlates with ZIKV disease symptoms. Our study provides insight into unlinked evolution of immune response to ZIKV infection and identified unique targets for ZIKV serodiagnostics.

4 March 2009 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
CBCinthya Estefhany Díaz Benítez
Cinthya Estefhany Díaz Benítez
KNKarla R. Navarro-Fuentes
Karla R. Navarro-Fuentes
JFJacqueline A. Flores-Sosa
Jacqueline A. Flores-Sosa
JJJanet Juárez-Díaz
Janet Juárez-Díaz
FUFelipe J. Uribe-Salas
Felipe J. Uribe-Salas
VMVicente Madrid-Marina
Vicente Madrid-Marina

16 February 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
PBPablo F. Belaunzarán-Zamudio
Pablo F. Belaunzarán-Zamudio
AMAllyson Mateja
Allyson Mateja
PDPaola del Carmen Guerra- de-Blas
Paola del Carmen Guerra- de-Blas
HRHéctor A. Rincón-León
Héctor A. Rincón-León
KNKarla Navarro-Fuentes
Karla Navarro-Fuentes
T(the Mexican Emerging Infectious Diseases Clinical Research Network (LaRed)
the Mexican Emerging Infectious Diseases Clinical Research Network (LaRed)
Background: Our purpose was to provide a detailed clinical description, of symptoms and laboratory abnormalities, and temporality in patients with confirmed Zika and dengue infections, and other acute illnesses of unidentified origin (AIUO). Methods/ Principal findings: This was a two-year, multicenter, observational, prospective, cohort study. We collected data from patients meeting the Pan American Health Organization’s modified case-definition criteria for probable Zika infection. We identified Zika, dengue chikungunya by RT-PCR in serum and urine. We compared characteristics between patients with confirmed Zika and dengue infections, Zika and AIUO, and Dengue and AIUO at baseline, Days 3,7,28 and 180 of follow-up. Most episodes (67%) consistent with the PAHO definition of probable Zika could not be confirmed as due to any flavivirus and classified as Acute Illnesses of Unidentified Origin (AIUO). Infections by Zika and dengue accounted for 8.4% and 16% of episodes. Dengue patients presented with fever, generalized non-macular rash, arthralgia, and petechiae more frequently than patients with Zika during the first 10 days of symptoms. Dengue patients presented with more laboratory abnormalities (lower neutrophils, lymphocytosis, thrombocytopenia and abnormal liver function tests), with thrombocytopenia lasting for 28 days. Zika patients had conjunctivitis, photophobia and localized macular rash more frequently than others. Few differences persisted longer than 10 days after symptoms initiation: conjunctivitis in Zika infections, and self-reported rash and petechia in dengue infections. Conclusions: Our study helps characterize the variety and duration of clinical features in patients with Zika, dengue and AIUO. The lack of diagnosis in most patients points to need for better diagnostics to assist clinicians in making specific etiologic diagnoses.

29 January 2026 in Journal of Global Health Economics and Policy
Verified
Journal Article
Open access
PDF file
Oscar Manuel Delgado CuellarOscar Manuel Delgado Cuellar
Oscar Manuel Delgado Cuellar
CMClemente Mosso-Gonzalez
Clemente Mosso-Gonzalez
JCJorge M Castañeda-Gomez
Jorge M Castañeda-Gomez
RBRebeca Basave-Carreon
Rebeca Basave-Carreon
JJJulio C Jan-Gomez
Julio C Jan-Gomez
KNKarla R Navarro-Fuentes
Karla R Navarro-Fuentes
Background: The clinical expression and severity of COVID-19 have shifted substantially throughout the pandemic owing to viral evolution, rising population immunity, and the expansion of vaccination. However, in Mexico, few studies have compared these changes across successive waves using primary clinical data from first- and second-level healthcare units. We aimed to characterize temporal changes in symptoms, clinical severity, and outcomes across six COVID-19 waves in a southern border city of Mexico, and to examine their correspondence with national patterns of variant predominance and vaccination coverage. Methods: We conducted a descriptive time-series study of confirmed COVID-19 cases treated in first- and second-level units of the Mexican Institute of Social Security in Tapachula, Chiapas, Mexico, from March 2020 to January 2023. Clinical, demographic, and epidemiological data were extracted from medical records and the SINOLAVE. Cases were classified into six epidemic waves. Clinical characteristics and severity indicators were compared across waves using chi-square or Fisher’s exact tests with Bonferroni correction. Predominant variants were inferred through temporal alignment with national genomic surveillance. Results: Among 18,319 suspected cases, 6,145 (47.1%) were confirmed. Severe disease, oxygen requirement, intubation, and mortality were concentrated in the first three waves, accounting for 88% of all intubations and 72% of deaths, coinciding with the circulation of unspecified lineages (waves 1–2) and the Delta variant (wave 3). Subsequent waves showed marked reductions in dyspnea, tachypnea, cyanosis, and chest pain, and a relative increase in upper-respiratory symptoms. Beginning with the fourth wave, corresponding to Omicron predominance and increasing vaccination coverage, hospitalizations, intubations, and mortality declined substantially. Conclusions: COVID-19 severity and symptom patterns changed markedly across the six waves in Tapachula, reflecting variant replacement and population immunity. These findings provide actionable evidence for health system planning and policy design in resource-limited border settings.

24 May 2024 in Ciencia Latina Revista Científica Multidisciplinar
Verified
Journal Article
Open access
PDF file
KFKarla Reyna Navarro Fuentes
Karla Reyna Navarro Fuentes
AAArturo Aguilar-Rojas
Arturo Aguilar-Rojas
ASAdriana Palacios Stempreiss
Adriana Palacios Stempreiss
SSSusana Sarasvati Rivas Santiago
Susana Sarasvati Rivas Santiago
MMMirna Melissa Gordillo Martínez
Mirna Melissa Gordillo Martínez
HLHéctor Armando Rincón León
Héctor Armando Rincón León
El estudio de factores asociados con la presentación del cáncer de mama es de gran interés para la salud pública. Los que son potencialmente modificables, como los patrones dietéticos, son relevantes por sus implicaciones en la prevención de la enfermedad. Con el objetivo de evaluar el efecto de una dieta rica en polifenoles como factor protector contra cáncer de mama, se realizó un estudio de casos y controles en 123 mujeres de Chiapas, México. Los casos fueron mujeres diagnosticadas con cáncer de mama de 2019 a 2021 y los controles mujeres con estudios de tamizaje con resultados BI-RADS 1 o 2 en el mismo período. Se aplicó un cuestionario sobre la ingesta de alimentos con alto contenido fenólico. Del grupo de frutas incluidas en el análisis, 4 mostraron asociación significativa con menor probabilidad de presentar la enfermedad, así como 5 verduras, 6 leguminosas, cereales y frutos secos, y 6 bebidas, especias y aceites. Estos hallazgos, realizados por primera vez en esta población, son consistentes con resultados previos en otras partes del mundo. Consideramos pertinente incorporar este conocimiento en las recomendaciones y consejería a las mujeres en la consulta y continuar con el estudio de estas asociaciones en las poblaciones afectadas.